„We are very happy for this recognition. During the last four years, our collaborative research has increased the visibility of Cologne as a hub for mitochondrial research. Mitochondria have been in the focus of research for many years, and are known as the powerhouse of the cell. Our CRC investigates how mitochondria communicate and signal to the cells to adapt their function to changing physiological conditions. Understanding this novel and dynamic aspect of mitochondrial function is crucial to unravel how these organelles affect several disease conditions. The strength of our consortium is that it brings together scientists with different backgrounds and technical expertise. We are very excited to be able to continue our studies and explore new hypotheses in the next four years“ says Elena Rugarli, spokesperson of CRC 1218 and CECAD Principal Investigator.
In addition to the University of Cologne, the Max Planck Institute for the Biology of Aging, the Max Planck Institute for Metabolic Research and a project at the University of Bonn are involved. The funding for the next four years amounts to approx. 9 M€.
Contact:
Prof. Dr. Elena Rugarli
Institute for Genetics / CECAD Research Center
University of Cologne
Joseph-Stelzmann-Str. 26
50931 Köln
Tel: +49 221 478 84244
Email: elena.rugarli@uni-koeln.de
Press contact:
Dr. Sibylle Grandel, CECAD Forschungszentrum
sgrandel@uni-koeln.de